Your browser version may not work well with NCBI's Web applications. More information
here...
-
[Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis]
[Article in Japanese]
Department of Clinical Laboratory, Tokyo Kyosai Hospital.
We performed basic and clinical studies in male gonococcal urethritis on a new oral antimicrobial agent, levofloxacin (LVFX, DR-3355), a new quinolone derivative. The antibacterial activity of LVFX against clinical strains of Neisseria gonorrhoeae was roughly comparable to that of ofloxacin, and ciprofloxacin. LVFX was administered to 10 males with gonococcal urethritis, 200 mg twice a day (8 cases) or 100 mg twice a day for 3 days (2 cases). Clinical evaluation was made according to the criteria of the Japanese UTI Committee. Overall efficacy rate was 100% (10/10). In the complication of chlamydia trachomatis (2 cases), efficacy rate was 100% (2/2). No subjective or objective adverse reactions occurred.
PMID: 1609678 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Ciprofloxacin (Cipro®, Cipro® XR , Proquin®XR)
Ciprofloxacin is an antibiotic used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent anthrax in people who may have been exposed to anthrax germs in the air. Cipr...
-
Ofloxacin Oral (Floxin®)
Ofloxacin is an antibiotic used to treat certain infections caused by bacteria, such as pneumonia; bronchitis; venereal disease (VD); and prostate, skin, and urinary tract infections. Antibiotics will not work for colds,...
-
Levofloxacin Oral (Levaquin®)
Levofloxacin is used treat infections such as pneumonia; chronic bronchitis; and sinus, urinary tract, kidney, and skin infections. Levofloxacin is in a class of antibiotics called fluoroquinolones. It works by eliminati...